This page shows the latest Cirara news and features for those working in and with pharma, biotech and healthcare.
To that end it recently bought late-stage stroke candidate Cirara (glyburide) from Remedy Pharma and an anti-tau antibody from Bristol-Myers Squibb for Alzheimer's disease.
Cirara vying to be first new treatment since the 1990s. Biogen has added to its late-stage pipeline with a licensing deal for Remedy Pharmaceuticals' Cirara, a drug candidate en route ... Cirara (RP-1127) is an intravenous formulation of glyburide, a
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...